VialVIAL
HomeDirectoryCompounding PharmacyMFV Compounding Pharmacy

Federal record

FDA Warning Letter issued August 15, 2025 · As of September 2026, Vial did not find a close-out letter in FDA records. Read the FDA letter →

We're providing this information based on regulatory filings Vial reviewed as of 2026-09-23. Regulatory status can change, and actions may be resolved or closed out. Confirm current status with the issuing agency: FDA.gov →

MFV Compounding Pharmacy
Compounding Pharmacy · GLP-1 & Weight Loss

MFV Compounding Pharmacy

Sandy, UT

Is this your company? Claim this profile.

MFV Compounding Pharmacy is a compounding pharmacy. The FDA issued a warning letter involving MFV Compounding Pharmacy on August 15, 2025, with no close-out letter found resolving it. Pricing was not publicly listed, so total cost should be confirmed before signing up.

What they offerGLP-1Weight Loss

38/100
Flagged
Why this score?

The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.

85-100High Confidence
70-84Well Documented
50-69Limited Confidence
0-49Flagged

MFV Compounding Pharmacy scores 38, in the Flagged band. The score moves when the public record changes. For MFV Compounding Pharmacy, the item most likely to move it: Pricing.

Payment never changes a score.

3 of 7 checks complete. The remaining checks have not been run yet. Missing checks reduce how complete the profile is. They are not a finding by themselves.

Score history

38 since September 2026. Last checked September 22, 2026.

What we found on MFV Compounding Pharmacy

We reviewed FDA enforcement records, OIG exclusions, DEA registration, and PCAB accreditation.

MFV Compounding Pharmacy is a Utah compounding pharmacy at 9550 S. State Street, Sandy, UT 84070. Its site lists compounded semaglutide and tirzepatide as sublingual troches and hormone replacement therapy, ordered by prescribers through a prescription portal.

The FDA issued a warning letter involving MFV Compounding Pharmacy on August 15, 2025. We have not found a close-out letter resolving it as of our last check (September 23, 2026); read the details below before going further. We could not independently verify a third-party certification or accreditation as of September 2026.

Why this score: 3 of 7 checks complete. Each links to the public source it was verified against.

Federal actions
Confirmed. See the full report for detail.
See the full report for the details of this record.
FDA.govOIG LEIEDEA Diversion
Checked September 30, 2026
Pricing
Not publicly listed
Not publicly listed. Confirm total monthly cost before enrolling.
Physicians named
Not publicly identified
NPI registration
Not checked yet
confirms a recognized healthcare entity in the federal registry.
PCAB accreditation
No PCAB accreditation on file as of 2026-09-22.
PCAB is the primary accreditation standard for compounding pharmacies.
ACHC / PCAB
Checked September 22, 2026
FDA 503B registration
Not checked yet
503B registration applies to outsourcing facilities; most compounders operate under 503A.
LegitScript certification
Not checked yet
not found is not failed. It means unconfirmed.
Show all evidence (7) Show fewer

A check we haven’t completed yet is not a mark against this provider. It just means we’re still sourcing that record. The score reflects what we’ve confirmed so far, and updates as more checks come in.

Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed September 22, 2026.

Our take

Vial Editorial

Based on the records and public materials we reviewed.

The FDA issued a warning letter to MFV Compounding Pharmacy on August 15, 2025. We have not found a close-out letter resolving it. Before using this compounding pharmacy, ask what changed after the letter and confirm current status with FDA.

Questions we’d want answered

LegitScript certification not found in our review
NPI not confirmed in federal registry
3 of 7 key checks found
4 important details still need to be confirmed directly.

Worth asking before you choose

Ask these before you sign up.

Screenshot these or show your doctor: they’re the same questions Vial would ask.

Compare record details

MedQuest Pharmacy has no federal action found; MFV Compounding Pharmacy has an FDA warning letter with no close-out letter found.

MFV Compounding Pharmacy scores 38, MedQuest Pharmacy scores 72.

MFV Compounding PharmacyMedQuest Pharmacy
Federal actionsConfirmedNone found
Vial Score38/10072/100
LegitScript certifiedNoNo
PCAB accreditedNoNo
States servedNot checkedNationwide (50 states)

What Vial measures, and what we don’t

We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.

Treatments offered

Other compounding pharmacy providers in Vial

Other Compounding Pharmacy in Vial’s directory. Open a profile, or compare side by side.

MedQuest PharmacyMedQuest Pharmacy6 of 8 checks complete
AnazaoHealthAnazaoHealth5 of 7 checks complete
Annovex Pharma, Inc.Annovex Pharma, Inc.5 of 7 checks complete
See 2 more alternativesShow fewer

Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.

Find your provider
Are you MFV Compounding Pharmacy?
Dispute findings by providing documentation
Dispute
Sources reviewed as of September 2026

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.